NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) --Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Pulmatrix, Inc. (NASDAQ: PULM), relating to the proposed merger with Cullgen, Inc. Under the terms of the agreement, Pulmatrix stockholders are expected to own approximately 3.6% of the combined company.Click here for more information https://monteverdelaw.com/case/pulmatrix-inc-pulm/. It is ...Full story available on Benzinga.com
Pulmatrix is a Massachusetts-based biopharmaceutical firm that develops and commercializes therapies for the treatment of pulmonary and non-pulmonary diseases.